Treatment Safety for Sensitive Dogs and Cats

Hypoallergenic and Low-Allergen Nutraceuticals from almapharm

Food allergies and intolerances or pet owners' concerns about them are steadily increasing. The clinical symptoms – ranging from dermatological problems such as itching and skin lesions to gastrointestinal disorders – are diverse and non-specific. The prevalence of intolerances varies greatly, ranging from 2% to 62% depending on the study. The study situation is very inconsistent and uses different terminologies:

• Food allergies (immunological)
• Food intolerances (non-immunological)*

When "hypoallergenic" is not equally "hypoallergenic"

When selecting suitable nutraceuticals, veterinary teams and pet owners often face a flood of products with incomplete or ambiguous declarations. In particular, the term "hypoallergenic" is not legally defined and is not used consistently in the feed sector – unlike in the food sector. For sensitive or predisposed patients, a helpful supplement quickly becomes an uncertainty factor:

• Which protein sources are included?
• Are there "hidden" allergens (e.g., yeast, milk components, or egg)?

Safety through clear labeling and reliability

Treatment safety therefore begins with transparency: Only when ingredients and potential allergens are clearly identifiable can a nutraceutical be integrated purposefully and responsibly into a diet and therapy concept.

• Hypoallergenic: consistently free of the most common known allergens
• Low-allergen: transparently labeled with only one potential allergen – to enable a targeted selection for known, specific sensitizations

This reliable classification helps you to provide the best and safest recommendation for your patients. It builds trust with pet owners and sustainably supports treatment success in dogs and cats with food intolerances.

Building trust with pet owners – an often underestimated safety factor

Pet owners of allergic animals are often uncertain: "What can I even give anymore?" The clear, comprehensible classification of almapharm products into hypoallergenic and low-allergen (1 allergen) makes advice tangible and reduces risks and incorrect applications. This improves:

• product selection for known allergies,
• communication with pet owners,
• compliance and treatment adherence
• and thus treatment success

Benefits at a glance

Safety	Transparency	Treatment Success
Clear framework for sensitive or predisposed patients.	Traceable declaration and quick orientation.	More trust from pet owners and better adherence to hypoallergenic and low-allergen management.

Download overview of application safety as PDF

Sources: *Verlinden, A. et al.: Food allergy in dogs and cats: a review. Critical reviews in food science and nutrition, 46(3), 259-273, (2006).